Respiratory & Anti-Allergic Tablet Franchise in Ahmedabad

Bilastuff AB 20 Tablet Supplier in Mumbai

Bilastine Acebrophylline Tablet Distributor in Delhi

Bronchodilator & Anti-Allergic Tablet Manufacturer in Bangalore

Asthma & Allergy Tablet Stockist in Hyderabad
Respiratory Therapy Tablet Exporter in Chandigarh

Home/Products /bilastine-20mg-acebrophylline-200mg-tablet

About the Product

Description


Bilastuff AB 20 Tablet combines Bilastine 20mg, a potent non-sedating H1-antihistamine, with Acebrophylline 200mg, a bronchodilator and mucolytic agent. This combination is designed to provide comprehensive relief in allergic and obstructive airway conditions by reducing histamine-induced symptoms and improving airway patency.

Clinically, it is indicated for bronchial asthma, chronic bronchitis, allergic rhinitis, and other respiratory hypersensitivity or obstructive conditions. Bilastine helps alleviate sneezing, nasal congestion, and itching, while Acebrophylline promotes bronchodilation, mucus clearance, and airway relaxation, enhancing overall respiratory function.

The tablet formulation ensures accurate dosing, consistent therapeutic effect, and rapid symptomatic relief, making it ideal for pulmonology clinics, ENT and allergy centers, hospitals, and specialty pharmacies. It supports improved airflow, symptom control, and enhanced patient comfort under medical supervision.

Bilastuff AB 20 Tablet helps in reducing airway inflammation, relieving nasal and bronchial allergy symptoms, improving lung function, and providing effective respiratory support. Its combination of antihistamine and bronchodilator effects makes it a trusted therapy for patients with asthma and allergic respiratory disorders.


Common side effects may include mild headache, dizziness, dry mouth, or gastrointestinal discomfort. Rarely, hypersensitivity reactions, palpitations, or sleep disturbances may occur.

Bilastuff AB 20 Tablet is indicated for the management of allergic rhinitis, chronic bronchitis, asthma, and other respiratory conditions characterized by bronchospasm, mucus retention, and allergic responses, as prescribed by a healthcare professional.

Use under medical supervision. Caution is advised in patients with renal or hepatic impairment. Avoid abrupt discontinuation of therapy. Not recommended during pregnancy or lactation unless specifically prescribed by a physician.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Bilastine 20mg + Acebrophylline 200mg Tablet in the PCD pharma franchise market?

This combination has strong demand in the respiratory and allergy segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on asthma, bronchitis, and allergic airway disease management.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of allergic rhinitis, bronchial asthma, COPD, wheezing, chest congestion, and respiratory inflammation with allergy triggers. Bilastine controls allergic symptoms like sneezing and runny nose Acebrophylline acts as a bronchodilator and mucoregulator, improving airflow Together, they provide dual action for allergy relief and improved breathing, strengthening a reliable respiratory-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong seasonal and chronic respiratory demand, pulmonologist and physician prescriptions, fast-moving respiratory category, reliable supply chain support, and good margins when partnering for this product.

How can I become a distributor or franchise partner for this tablet?

Medical distributors, stockists, and wholesalers interested in this combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, pricing, and distribution support.